Related Experiment Video
Updated: Jul 25, 2025

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Invasive Fungal Infections Associated with COVID-19
Kyaw M Hlaing1, Lea M Monday1, Marcio Nucci2
1Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Abstract:
The COVID-19 pandemic caused >6 million deaths worldwide, often from respiratory failure. Complications frequently occurred in hospitalized patients, particularly in the intensive care unit. Among these, fungal infections were a cause of high morbidity and mortality. Invasive aspergillosis, candidiasis and mucormycosis were the most serious of these infections. Risk factors included alterations in immune defense mechanisms by COVID-19 itself, as well as immunosuppression due to various therapies utilized in severely ill patients. Diagnosis was often challenging due to lack of sensitivity of current testing. Outcomes were generally poor, due to significant co-morbidities and delayed diagnosis, with mortality rates >50% in some studies. High index of clinical suspicion is needed to facilitate early diagnosis and initiation of appropriate antifungal therapy.
Insights
Fungal infections like invasive aspergillosis complicated severe COVID-19, increasing mortality. Early diagnosis and antifungal therapy are crucial for better outcomes in critically ill patients.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Mycology
Background:
- The COVID-19 pandemic resulted in millions of deaths, frequently due to respiratory failure.
- Hospitalized patients, especially in intensive care units (ICUs), experienced severe complications.
- Fungal infections, including invasive aspergillosis, candidiasis, and mucormycosis, significantly contributed to morbidity and mortality.
Purpose of the Study:
- To highlight the significant burden of fungal infections in COVID-19 patients.
- To discuss the risk factors and diagnostic challenges associated with these infections.
- To emphasize the need for early diagnosis and treatment to improve patient outcomes.
Main Methods:
- Review of clinical data and literature concerning fungal infections in COVID-19 patients.
- Analysis of risk factors, including viral-induced immune alterations and therapeutic immunosuppression.
- Evaluation of diagnostic limitations and their impact on patient management.
Main Results:
- COVID-19 patients, particularly those in ICUs, are at high risk for invasive fungal infections.
- Risk factors include COVID-19's impact on immune defenses and immunosuppressive therapies.
- Current diagnostic tests often lack sensitivity, leading to delayed diagnosis.
- Mortality rates for these fungal infections can exceed 50% in some patient cohorts.
Conclusions:
- Invasive fungal infections pose a serious threat to critically ill COVID-19 patients.
- A high index of clinical suspicion is essential for prompt diagnosis.
- Early initiation of appropriate antifungal therapy is critical for improving survival rates.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Endocarditis II: Clinical Features of Infective Endocarditis
Fungal Phylum Basidiomycota

